AbbVie ROA Ratio 2011-2026 | ABBV

Annual ROA Ratio AbbVie

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.36	3.17	3.61	8.53	7.88	3.07	8.84	9.58	7.5	9.01	9.7	6.44	14.14	19.53	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19.53	1.36	8.02

Quarterly ROA Ratio AbbVie

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.86	3.68	3.92	4.28	4.69	3.9	5.77	7.26	8.9	9.06	11.82	8.03	8.55	7.77	5.04	4.44	3.43	3.07	6.19	6.77	8.09	8.84	2.63	5.14	7.65	9.58	12.73	10.41	9.77	7.5	9.53	9.64	9.37	9.01	9.76	9.68	9.82	9.7	3.89	3.4	4.81	6.44	13.25	14.71	14.38	14.14	15.98	18.54	19.58	19.53	13.83	7.96	3.27	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.58	2.63	8.53

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Alnylam Pharmaceuticals ALNY	6.32	$ 330.34	3.6 %	$ 43.3 B	USA
BioLineRx Ltd. BLRX	-33.24	$ 2.25	1.81 %	$ 908 M	Israel
I-Mab IMAB	7.43	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Anavex Life Sciences Corp. AVXL	-44.67	$ 2.96	-1.0 %	$ 252 M	USA
Applied Molecular Transport AMTI	-117.57	-	-	$ 10.1 M	USA
BioNTech SE BNTX	65.02	$ 91.28	0.11 %	$ 27.2 B	Germany
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-19.87	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Allena Pharmaceuticals ALNA	-140.01	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	-20.15	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	-206.44	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	-52.23	$ 4.09	-0.97 %	$ 437 M	USA
Aravive ARAV	-122.8	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	-24.26	$ 8.22	2.37 %	$ 225 M	Israel
Aptose Biosciences APTO	-254.37	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	0.11	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-44.38	$ 31.37	1.0 %	$ 2.08 B	USA
Avenue Therapeutics ATXI	-99.25	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	12.03	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	-428.94	-	-16.42 %	$ 249 M	USA
Arcutis Biotherapeutics ARQT	-3.73	$ 23.66	0.11 %	$ 3.01 B	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-34.23	-	-	$ 546 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-49.15	-	-5.38 %	$ 6.06 M	USA
Ardelyx ARDX	-12.28	$ 5.97	0.51 %	$ 1.44 B	USA
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	-26.5	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	-150.49	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
AlloVir ALVR	-35.68	-	4.14 %	$ 49.1 M	USA
argenx SE ARGX	-14.32	$ 748.25	0.25 %	$ 25 B	Niderland